Patents by Inventor Peter Matthew Tessier

Peter Matthew Tessier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AND USE THEREOF
    Publication number: 20220064283
    Abstract: The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 3, 2022
    Inventors: Peter Matthew Tessier, Samuel D. Stimple, Arne Staby
  • Antibodies and use thereof
    Patent number: 11208477
    Abstract: The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: December 28, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Peter Matthew Tessier, Samuel D. Stimple, Arne Staby
  • ANTIBODIES AND USE THEREOF
    Publication number: 20200308274
    Abstract: The present invention relates to specific antibodies and use thereof, such as for identifying and/or quantifying liraglutide fibrils and/or semaglutide fibrils.
    Type: Application
    Filed: March 31, 2020
    Publication date: October 1, 2020
    Applicants: Novo Nordisk A/S, Regents of the University of Michigan, Regents of the University of Michigan
    Inventors: Peter Matthew Tessier, Samuel D. Stimple, Arne Staby